what happens when glp 1 is stopped Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights Many adults stop GLP-1 therapy

marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]

A few human studies support this effect, too, though more research on plaque reduction is required to confirm this benefit

High), including those with ASCVD or high cardiovascular risk (Class III

placebo)

The drug has also, reports Reuters, significantly reduced blood lipid levels and cardiovascular risk at early stages

Determining the appropriate dose and dosing regimen, for example, requires pharmaceutical companies to navigate a finely balanced set of variables to ensure a drug delivers the optimal effect with minimal impact on the patient